Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

SARS-CoV-2 spike produced in insect cells elicits high neutralization titres in non-human primates

1 Jan 2020

Abstract excerpt

The current coronavirus disease 2019 (COVID-19) pandemic was the result of the rapid transmission of a highly pathogenic coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), for which there is no efficacious vaccine or therapeutic. Toward the development of a vaccine, here we expressed and evaluated as potential candidates four versions of the spike (S) protein using an insect cell...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to COVID-19 Clinical Research Studies
Share to Mosquito-borne diseases and control
Share to SARS-CoV-2 and COVID-19 Research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 32897177
DOI: 10.1080/22221751.2020.1821583

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

SARS-CoV-2 spike produced in insect cells elicits high neutralization titres in non-human primatesPMID 32897177Read ↗

The SARS-CoV-2 Spike Glycoprotein Biosynthesis, Structure, Function, and Antigenicity: Implications for the Design of Spike-Based Vaccine ImmunogensSemantic proximity Read ↗

Recombinant SARS-CoV-2 spike proteins for sero-surveillance and epitope mappingSemantic proximity Read ↗

Molecular biology of the SARs-CoV-2 spike protein: A review of current knowledge.Semantic proximity Read ↗

Stabilizing the Closed SARS-CoV-2 Spike TrimerSemantic proximity Read ↗

SARS-CoV-2 Virus-like Particles Produced by a Single Recombinant Baculovirus Generate Anti-S Antibody and Protect against Variant ChallengeSemantic proximity Read ↗

A broadly protective CHO cell expressed recombinant spike protein subunit vaccine (IMT-CVAX) against SARS-CoV-2Semantic proximity Read ↗

Characterization of the SARS-CoV-2 S Protein: Biophysical, Biochemical, Structural, and Antigenic AnalysisSemantic proximity Read ↗

Implications for SARS-CoV-2 Vaccine Design: Fusion of Spike Glycoprotein Transmembrane Domain to Receptor-Binding Domain Induces TrimerizationSemantic proximity Read ↗

Stabilizing the closed SARS-CoV-2 spike trimer.Semantic proximity Read ↗

Structural impact on SARS-CoV-2 spike protein by D614G substitutionSemantic proximity Read ↗

Novel Spike-stabilized trimers with improved production protect K18-hACE2 mice and golden Syrian hamsters from the highly pathogenic SARS-CoV-2 Beta variantSemantic proximity Read ↗

Structure-based Design of Prefusion-stabilized SARS-CoV-2 SpikesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.